France Debates Vaccine Safety

June 1, 2014December 10, 2018Big Pharma

Total0
0
0
0
Like

Share via

by Norma Erickson

On May 22, two conferences were held at the National Assembly on the subject of aluminum adjuvants in vaccines and the safety of HPV vaccines. (View the announcement here.)

Organized by E3M and hosted by Virginia Belle, the morning conference was entitled, “Aluminum and Vaccines: International Expertise Demands Action.” (View schedule here.) Scientists and medical professionals from various countries around the world were invited to present their research in an open forum to members of the French Parliament and French National Health Authorities with journalists and television cameras present.

Professors Romain Gherardi and Jerome Authier informed the audience of the preliminary results of their research which was funded by MSNA (the French Medicines Agency) which indicated a causal link between aluminum adjuvants and adverse events experienced after vaccination stating:

We injected normal mice, without any particular background, with either PBS as a control serum, or the hepatitis B vaccine, Engerix. We did cognitive and motor testing at various intervals. We have the results of the first two times. At 45 days, there is no difference between the control group and the vaccinated group. By contrast, at 135 days (4 ½ months), three tests are significantly altered in the vaccinated mice only. What are these tests? Tests of anxiety, decreased activity, decreased stamina (including motor endurance), that is to say a series of symptoms resembling that exactly described by patients of chronic macrophagic myofasciitis.

Widget not in any sidebars

Dr. Sin Hang Lee, described his Gardasil research to date, stating:

I have tested 16 samples of the HPV vaccine Gardasil, each of different lot number, from 9 countries, and found that they all contained fragments of residual HPV DNA, namely viral DNA which was used to manufacture the HPV vaccine antigens by a genetic engineering technology.

Furthermore, the viral DNA fragments in a non-B conformation were firmly bound to the aluminum adjuvant in the vaccine by ligand exchange, an inadvertently created chemical compound containing viral DNA which can be transfected into the host cells, namely the human phagocytes and macrophages.

Based on established research, this viral DNA can activate the innate immune system of the macrophages to generate and release cytokines, including tumor necrosis factor in the vaccine recipients.

In certain genetically predisposed individuals, the level of tumor necrosis factor may be high enough to cause hypotension, fainting, tachycardia, unexpected sudden death and acute disseminated encephalomyelitis, namely adverse reactions which have been documented following Gardasil vaccination.

Professor Belec, head of the Laboratory of Virology, Hospital European Georges Pompidou, confirmed the work of Dr. Lee on Gardasil, stating:

We found residual viral DNA fragments, which should not be there. This is true residual contamination, probably related to the manufacturing process. Between 200 and 400 fragments of residual DNA in Gardasil. This is not normal.

What is the meaning? I do not know. Dr. Lee showed us in his work that this fragment was associated with aluminum hydroxyphosphate. This is not any normal way.

This is but a sample of the information presented during the conferences held in Paris on the 22nd of May. The schedule for the day with a list of speakers is available here. All 16 presentations and the two very informative debates can be viewed in their entirety on the OPECST site.

At the conclusion of the morning session as a direct result of having the opportunity to hear both sides of the vaccine debate, the parliamentarians who were present (Jean-Louis Roumegas Danielle Auroi, Laurence Cohen, Jean Lassalle, and Sophie Errante) called upon the French government to:

Massively support rapid research so that the consequences of the accumulation of aluminum in the brain are established quickly and comprehensively
Make vaccines available without aluminum adjuvants
Not promote any campaign of mass vaccination with vaccines containing aluminum, as research has not provided satisfactory answers to safety questions
Recognize the group Action on Health

For the first time in France, open public debates have been held with arguments being heard from both vaccine promoters and vaccine safety advocates. These historic events need to be duplicated in every country around the globe.

Dr. Izard, himself a victim of macrophagic myofaciitis, stated it quite succinctly during his presentation when he said:

Pending the results of this work, the precautionary principle should apply. The population must have access to vaccines without aluminum adjuvants. The widespread vaccination against HPV should be put under immediate moratorium.

Senator and co-chair of the debate sponsored by OPECST, Corinne Bouchoux, proposed research be funded to discover treatment protocols for those suffering adverse events post-vaccination.

The debates in France were about more than HPV vaccines, but one has to remember HPV vaccines are a prime example of what can go wrong with a hastily instituted vaccination program.

As a society, we are injecting a healthy population of young people hoping that eliminating one of the risk factors for the development of cancer will make an impact on the disease prevalence – albeit decades down the road. Contamination with a new chemical compound that has completely unknown health consequences has been discovered and documented by two separate independent laboratories. Said contamination has been swept under the FDA/CDC carpet. Victims of adverse events are told it is all in their mind, coincidence, etc…

HPV vaccines are not the first time this type of scenario has played out. The time has come to stop discrediting those who discover something not quite right with any particular vaccine. The time has come to look at their findings and investigate to see if there is indeed a problem.

The time has come for government health authorities to meet the survivors of adverse reactions after HPV vaccinations face to face. The time has come to acknowledge vaccine injuries and find out how and why they happen. The time has come for open scientific investigation and debate.

Given all of the facts, perhaps more governments would choose precaution over promotion. Given all of the facts, perhaps more governments would choose science over psychosomatic.

Given all of the facts, medical consumers would actually be allowed to exercise their right to make informed choices.

Norma Erickson is the President of SaneVax, Inc., where this article first appeared.